Posted by 3 Beer Effect on June 23, 2002, at 17:42:53
I came across a medication listed on the internet that was in phase II clinical trials way back in the year 2000 for Attention Deficit Disorder. It was being developed by Glaxo SmithKline Beecham (GSK) formerly known as Glaxo Wellcome.
It is called GW320659 and is a norepinephrine/dopamine reuputake inhibitor.
Is this a less toxic, non-seizure causing, analog or improvement upon Wellbutrin SR?
Is there a name for this compound & what is the status of it in clinical trials, FDA approval etc?
Any other additional info about GW320659 or other upcoming improved/less toxic versions of Wellbutrin would be appreciated.
Thanks,
3 Beers.........
poster:3 Beer Effect
thread:110565
URL: http://www.dr-bob.org/babble/20020617/msgs/110565.html